WuXi AppTec Co., Ltd.

Research WuXi AppTec Co., Ltd. (2359.HK) on Bullrun: market cap HKD 595.45B, P/E 23.8, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 595.45B; P/E is 23.8; dividend yield is 1.2%.

Peer valuation comparison

Latest P/E is 23.81x versus a Healthcare sector median of 21.69x (9.8% above).

Latest dividend yield is 1.22% versus a Healthcare sector median of 2.41% (49.4% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 595.45B23.80.6%1.18

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.18 HKD, yield 1.2%.

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

WuXi XDC Cayman Inc. (2268.HK) Yunkang Group Limited (2325.HK) BGI Genomics Co., Ltd (300676.SZ) Hangzhou Tigermed Consulting Co., Ltd (3347.HK) WuXi AppTec Co., Ltd. (603259.SS) Joinn Laboratories(China)Co.,Ltd. (6127.HK) Mega Genomics Limited (6667.HK) Biosino Bio-Technology and Science Incorporation (8247.HK) Adicon Holdings Limited (9860.HK) Kindstar Globalgene Technology, Inc. (9960.HK) Burning Rock Biotech Ltd (BNR) Shandong Dong-Ee Jiao Co Ltd (000423.SZ)

Frequently asked questions

What is WuXi AppTec Co., Ltd.'s market cap?

WuXi AppTec Co., Ltd.'s market capitalization is HKD 595.45B.

What is WuXi AppTec Co., Ltd.'s P/E ratio?

WuXi AppTec Co., Ltd.'s price-to-earnings (P/E) ratio is 23.8.

Does WuXi AppTec Co., Ltd. pay a dividend?

WuXi AppTec Co., Ltd. has a dividend yield of 1.2%.

What does WuXi AppTec Co., Ltd. do?

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments.